These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Treatment with arbekacin of surgical infections by resistant strains of Staphylococcus aureus. Arbekacin Study Group]. Morimoto K; Nakatani S; Kaji M; Kinoshita H; Fujimoto M; Hirata S; Ueda T; Tamate S; Yamazaki O Jpn J Antibiot; 1994 Jun; 47(6):826-36. PubMed ID: 8072193 [TBL] [Abstract][Full Text] [Related]
5. [Epidemiological study of Arbekacin-resistant, methicillin resistant Staphylococcus aureus in Saitama Medical School Hospital]. Yamazaki T; Endo K; Tominaga K; Fukuda M; Maesaki S; Hashikita G; Itabashi A Kansenshogaku Zasshi; 2004 Apr; 78(4):305-11. PubMed ID: 15176234 [TBL] [Abstract][Full Text] [Related]
6. [Clinical efficacy of arbekacin in patients with methicillin-resistant Staphylococcus aureus infections. Research Group of MRSA Forum]. Nasuhara K; Takatsuka K; Takatsuka N; Teraoka M; Tokita S; Shinohara M; Azuma E; Saijo N; Sone H; Saito I Jpn J Antibiot; 1994 Jun; 47(6):720-30. PubMed ID: 8072180 [TBL] [Abstract][Full Text] [Related]
7. [Clinical effect of the combined therapy of arbekacin and imipenem/cilastatin against methicillin-resistant Staphylococcus aureus]. Hashimoto A; Ohtsubo T; Tomono K; Kaku M; Koga H; Kohno S; Hara K; Sugiyama H; Taira K; Inoue Y Jpn J Antibiot; 1994 Jun; 47(6):804-12. PubMed ID: 8072190 [TBL] [Abstract][Full Text] [Related]
8. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. IV. Combined effects of arbekacin with cefmetazole or flomoxef]. Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Suzuki K; Fukayama S; Ishihara R; Oda S Jpn J Antibiot; 1992 Oct; 45(10):1312-8. PubMed ID: 1479683 [TBL] [Abstract][Full Text] [Related]
9. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. II. The combined effect of arbekacin with imipenem or cefminox]. Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S Jpn J Antibiot; 1992 Aug; 45(8):958-64. PubMed ID: 1433902 [TBL] [Abstract][Full Text] [Related]
10. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. I. The combined effect of arbekacin with fosfomycin or clavulanic acid/ticarcillin]. Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S Jpn J Antibiot; 1992 Aug; 45(8):949-57. PubMed ID: 1433901 [TBL] [Abstract][Full Text] [Related]
11. [Antibacteriological activities of arbekacin and vancomycin against strains of MRSA]. Ishii T; Takayama Y; Takase Y; Orikasa Y Jpn J Antibiot; 1994 Jun; 47(6):647-54. PubMed ID: 8072173 [TBL] [Abstract][Full Text] [Related]
12. [Antibiotic efficacies of combined uses of arbekacin and various antibiotics against methicillin-resistant Staphylococcus aureus]. Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R; Oda S Jpn J Antibiot; 1994 Jun; 47(6):693-700. PubMed ID: 8072177 [TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy for infections due to methicillin-resistant Staphylococcus aureus with combination therapy by cefuzonam and fosfomycin or minocycline in the urologic field. Matsumoto T; Kubo S; Haraoka M; Takahashi K; Tanaka M; Sakumoto M; Kumazawa J Clin Ther; 1993; 15(5):819-28. PubMed ID: 8269448 [TBL] [Abstract][Full Text] [Related]
14. Bactericidal activity of arbekacin against methicillin-resistant Staphylococcus aureus. Comparison with that of vancomycin. Aoki Y Jpn J Antibiot; 1994 Jun; 47(6):640-6. PubMed ID: 8072172 [TBL] [Abstract][Full Text] [Related]
16. [Clinical efficacy of arbekacin in deep MRSA infection. Including follow-up study after the termination of chemotherapy]. Kuwabara M; Konishi F; Yokoyama T; Kodama T; Santoh T; Nakai S; Miyoshi N; Kurimura T; Miyazawa T; Arita K Jpn J Antibiot; 1994 Jun; 47(6):771-80. PubMed ID: 8072186 [TBL] [Abstract][Full Text] [Related]
17. [Bacteriological evaluations of combination effects with cefotiam and other antimicrobial agents against methicillin-resistant Staphylococcus aureus. II. Synergistic actions of cefotiam with arbekacin and minocycline]. Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R Jpn J Antibiot; 1993 Feb; 46(2):123-9. PubMed ID: 8331772 [TBL] [Abstract][Full Text] [Related]
18. Trends of arbekacin-resistant MRSA strains in Japanese hospitals (1979 to 2000). Tsuchizaki N; Ishino K; Saito F; Ishikawa J; Nakajima M; Hotta K J Antibiot (Tokyo); 2006 Apr; 59(4):229-33. PubMed ID: 16830890 [TBL] [Abstract][Full Text] [Related]
19. [Susceptibility of methicillin-resistant Staphylococcus aureus to various antibiotics. Classification by aminoglycoside-modifying enzymes and antibiotics active against MRSA]. Kondo S; Ikeda Y; Hattori S; Hamada M; Takeuchi T Jpn J Antibiot; 1991 Nov; 44(11):1211-5. PubMed ID: 1664469 [TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activity of arbekacin, a new aminoglycoside antibiotic, against methicillin-resistant Staphylococcus aureus. Inoue M; Nonoyama M; Okamoto R; Ida T Drugs Exp Clin Res; 1994; 20(6):233-9. PubMed ID: 7758395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]